SELLAS Life Sciences Group, Inc. (SLS) Misses Q3 EPS by 35c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q3 EPS of ($0.33), $0.35 worse than the analyst estimate of $0.02.

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• Oddity Tech Ltd. (ODD) Tops Q2 EPS by 1c
• Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance